相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
James W. Murrough et al.
BIOLOGICAL PSYCHIATRY (2013)
Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Antidepressant Efficacy of Ketamine in Depressed Patients
Gonzalo Laje et al.
BIOLOGICAL PSYCHIATRY (2012)
Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression
David A. Luckenbaugh et al.
BIPOLAR DISORDERS (2012)
Ketamine as a Novel Antidepressant: From Synapse to Behavior
J. W. Murrough
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Ketamine for Treatment-Resistant Unipolar Depression Current Evidence
Sanjay J. Mathew et al.
CNS DRUGS (2012)
Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled Study
Lobna Ibrahim et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Synaptic Dysfunction in Depression: Potential Therapeutic Targets
Ronald S. Duman et al.
SCIENCE (2012)
Brain derived neurotrophic factor, cardiopulmonary fitness and cognition in patients with coronary artery disease
W. Swardfager et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Anita E. Autry et al.
NATURE (2011)
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
Marije aan het Rot et al.
BIOLOGICAL PSYCHIATRY (2010)
The depression-executive dysfunction (DED) syndrome and response to antidepressants: a meta-analytic review
Skye N. McLennan et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2010)
Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial
Sanjay J. Mathew et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls
Celia J. A. Morgan et al.
ADDICTION (2009)
Family History of Alcohol Dependence and Initial Antidepressant Response to an N-methyl-D-aspartate Antagonist
Laura E. Phelps et al.
BIOLOGICAL PSYCHIATRY (2009)
Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential
Laetitia Mony et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Neuropsychological characteristics as predictors of SSRI treatment response in depressed subjects
Marianne Gorlyn et al.
JOURNAL OF NEURAL TRANSMISSION (2008)
Psychiatric safety of ketamine in psychopharmacology research
Edward B. Perry et al.
PSYCHOPHARMACOLOGY (2007)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Psychomotor slowing as a predictor of Fluoxetine nonresponse in depressed outpatients
BP Taylor et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers
A Parwani et al.
PSYCHOPHARMACOLOGY (2005)
Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine - Implications for glutamatergic and dopaminergic model psychoses and cognitive function
JH Krystal et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Selective cognitive impairments associated with NMDA receptor blockade in humans
LM Rowland et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers
CJA Morgan et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Executive dysfunction predicts nonresponse to fluoxetine in major depression
JJ Dunkin et al.
JOURNAL OF AFFECTIVE DISORDERS (2000)
Attenuation of the neuropsychiatric effects of ketamine with lamotrigine -: Support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists
A Anand et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Effects of (S)-ketamine on striatal dopamine: a [C-11]raclopride PET study of a model psychosis in humans
FX Vollenweider et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2000)
分享论文
